Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis
This clinical trial will test whether AGB101 (low-dose levetiracetam, 220 mg, extended release tablet) can improve symptoms of psychosis in Parkinson's disease…
Parkinson Disease Psychosis
Johns Hopkins UniversityNCT05824728
Phase 4
Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases
It is hypothesize that patients with clinically diagnosed neurodegenerative diseases will have significantly different receptor occupancy of 5HT2A receptors co…
Neurodegenerative DiseasesParkinson DiseaseParkinson Disease Psychosis
Vanderbilt University Medical CenterNCT05357612